Medical-Industrial Translational Research Center
Shinya Watanabe has not added Biography.
If you are Shinya Watanabe and would like to personalize this page please email our Author Liaison for assistance.
[Transcriptome analysis of virus-infected cells].
Uirusu Jun, 2004 | Pubmed ID: 15449901
Na+ -Ca2+ exchanger expression and its modulation.
Biological & pharmaceutical bulletin Mar, 2009 | Pubmed ID: 19252272
Cathepsin L is highly expressed in gastrointestinal stromal tumors.
International journal of oncology Nov, 2011 | Pubmed ID: 21769426
Somatic 15q break after long-term stable disease in acute myeloid leukemia.
Clinical lymphoma, myeloma & leukemia Apr, 2014 | Pubmed ID: 24361186
Enhanced expression of retinoic acid receptor alpha (RARA) induces epithelial-to-mesenchymal transition and disruption of mammary acinar structures.
Molecular oncology Feb, 2015 | Pubmed ID: 25300573
FAM83B is a novel biomarker for diagnosis and prognosis of lung squamous cell carcinoma.
International journal of oncology Mar, 2015 | Pubmed ID: 25586059
Hepatocyte nuclear factor 1 beta induces transformation and epithelial-to-mesenchymal transition.
FEBS letters 04, 2016 | Pubmed ID: 27001343
Construction of a novel cell-based assay for the evaluation of anti-EGFR drug efficacy against EGFR mutation.
Oncology reports Jan, 2017 | Pubmed ID: 27840973
Comparative analysis of gene regulatory networks of highly metastatic breast cancer cells established by orthotopic transplantation and intra-circulation injection.
International journal of oncology Feb, 2017 | Pubmed ID: 28000849
Autocrine and Paracrine Interactions between Multiple Myeloma Cells and Bone Marrow Stromal Cells by Growth Arrest-specific Gene 6 Cross-talk with Interleukin-6.
The Journal of biological chemistry 03, 2017 | Pubmed ID: 28154173
Clinicopathological examination of dipeptidase 1 expression in colorectal cancer.
Biomedical reports Apr, 2017 | Pubmed ID: 28413640
A novel gene expression scoring system for accurate diagnosis of basaloid squamous cell carcinoma of the esophagus.
International journal of oncology Sep, 2017 | Pubmed ID: 28731134
[Exploring the Possibility of New Biomarkers of Immune Checkpoint Inhibitors for Non-Small Cell Lung Cancer (NSCLC)].
Gan to kagaku ryoho. Cancer & chemotherapy Sep, 2017 | Pubmed ID: 28912405
Evaluation system for arrhythmogenic potential of drugs using human-induced pluripotent stem cell-derived cardiomyocytes and gene expression analysis.
The Journal of toxicological sciences , 2017 | Pubmed ID: 29142174
TBX19 is overexpressed in colorectal cancer and associated with lymph node metastasis.
Fukushima journal of medical science Dec, 2017 | Pubmed ID: 29199261
Family with sequence similarity 83, member B is a predictor of poor prognosis and a potential therapeutic target for lung adenocarcinoma expressing wild-type epidermal growth factor receptor.
Oncology letters Feb, 2018 | Pubmed ID: 29434849
Prognostic Impact of Tumor Mutation Burden in Patients With Completely Resected Non-Small Cell Lung Cancer: Brief Report.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 08, 2018 | Pubmed ID: 29654927
Evaluation of anticancer agents using patient-derived tumor organoids characteristically similar to source tissues.
Oncology reports Aug, 2018 | Pubmed ID: 29917168
Establishment and Characterization of a Novel Human Clear-cell Sarcoma of Soft-tissue Cell Line, RSAR001, Derived from Pleural Effusion of a Patient with Pleural Dissemination.
Anticancer research Sep, 2018 | Pubmed ID: 30194147
A method of producing genetically manipulated mouse mammary gland.
Breast cancer research : BCR 01, 2019 | Pubmed ID: 30611295
An In Vitro System for Evaluating Molecular Targeted Drugs Using Lung Patient-Derived Tumor Organoids.
Cells 05, 2019 | Pubmed ID: 31137590
Prediction of lymphovascular space invasion in endometrial cancer using the 55-gene signature selected by DNA microarray analysis.
PloS one , 2019 | Pubmed ID: 31557240
Tumor mutation burden and immunological, genomic, and clinicopathological factors as biomarkers for checkpoint inhibitor treatment of patients with non-small-cell lung cancer.
Cancer immunology, immunotherapy : CII Jan, 2020 | Pubmed ID: 31807880
Establishment and characterization of highly osteolytic luminal breast cancer cell lines by intracaudal arterial injection.
Genes to cells : devoted to molecular & cellular mechanisms Feb, 2020 | Pubmed ID: 31849141
A highly sensitive trap vector system for isolating reporter cells and identification of responsive genes.
Biology methods & protocols , 2018 | Pubmed ID: 32161797
Proliferative Classification of Intracranially Injected HER2-positive Breast Cancer Cell Lines.
Cancers Jul, 2020 | Pubmed ID: 32640677
A Blood-based Gene-expression Scoring System for Cancer Screening in Patients With Branch-duct Intraductal Papillary Mucinous Neoplasms.
Anticancer research Nov, 2020 | Pubmed ID: 33109597
Clinical implication of oncogenic somatic mutations in early-stage cervical cancer with radical hysterectomy.
Scientific reports 10, 2020 | Pubmed ID: 33127935
Clinical relevance of oncogenic driver mutations identified in endometrial carcinoma.
Translational oncology Mar, 2021 | Pubmed ID: 33450701
Tumor β-catenin expression is associated with immune evasion in non-small cell lung cancer with high tumor mutation burden.
Oncology letters Mar, 2021 | Pubmed ID: 33574942
Establishment of reporter cells that respond to glucocorticoids by a transposon-mediated promoter-trapping system.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences Jul, 2021 | Pubmed ID: 33775826
Construction of patient-derived tumor models to evaluate anticancer agents and cancer immunotherapy.
Oncology letters May, 2021 | Pubmed ID: 33841567
A screening system for identifying interacting proteins using biomolecular fluorescence complementation and transposon gene trap.
PloS one , 2021 | Pubmed ID: 33989302
ACERCA DE JoVE
Copyright © 2024 MyJoVE Corporation. Todos los derechos reservados